excluding the above, with the same age criteria. We examined reasons for admissions (ICD-10), length of stay and in-hospital mortality. We used indirect standardisation and Poisson modelling to derive proportional ratios adjusting for age group and sex.
Results There were 324,055 Parkinson's disease admissions in 182,859 patients over 4 years which included 232,905 non-elective admissions (72%). This resulted in expenditure of £907 million (£777 million for non-elective admissions). The main reasons for admission were pneumonia (13.5%), motor decline (9.4%), urinary tract infection (9.2%), and hip fractures (4.3%). These conditions occurred 1.5 to 2.6 times more frequently in patients than controls. Patients with Parkinson's disease were almost twice as likely to stay in hospital for more than 3 months (ratio 1.90, 95% CI 1.83, 1.97) and even more likely die in hospital (ratio 2.46, 95% CI 2.42, 2.49).
Conclusions
Parkinson's disease patients in England have higher rates of emergency admissions with longer hospital stays, higher costs and in-hospital mortality. Urgent attention should be given to developing cost-effective interventions to reduce the burden of hospitalisation for patients, carers and healthcare systems.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT

INTRODUCTION
With the ageing of the population in developed countries, the number of people affected by Parkinson's disease (PD) will rise [1] with the inevitable dramatic increase in healthcare costs of hospitalisation. A greater understanding is required about the whole process of hospitalisation in PD patients including why they are admitted, what happens during admission, and what happens on discharge. Only then can we develop improved processes to prevent or better manage hospitalisation.
Most previous studies have examined PD admissions to individual hospitals, [2] [3] [4] [5] [6] with relatively small sample sizes. One recent regional study from New South Wales, Australia documented the reasons for 5,637 admissions over a 4 year period. [7] The largest study came from an administrative database study in Ontario, Canada in 2003 with 15,304 PD patients. This showed that PD led to increased hospital admissions, longer admissions, higher drug costs, and higher physician costs. [8] There is a need for an up-to-date examination of PD admissions on a nationwide basis to inform healthcare planning.
We have examined the English Hospital Episode Statistics (HES) data on all admissions related to PD over a 4 year period to establish the size of the problem, the direct healthcare costs of admissions, the reasons why patients were admitted, and hospital mortality with the aim of recommending initiatives to reduce the burden of PD admissions.
METHODS
Data source
The HES database contains records including patient admissions, outpatient appointments and accident and emergency (A&E) attendances at healthcare providers (predominantly hospitals) in English NHS hospitals and English National Health Service (NHS) commissioned activity in the independent sector. [9] This includes zero bed days (ZBDs), where patients were admitted and discharged within 24 hours. These data are submitted to allow hospitals to be paid for the services they deliver.
For this study, hospital admissions within the HES database between 1st April 2009 and 31st March 2013 were extracted. The data was anonymised, so the study constituted a service evaluation which did not require ethical committee approval.
Diagnoses were recorded using the International Classification of Diseases, 10 th Revision (ICD-10). The main reason leading to an admission was coded as the primary diagnosis. Only one primary diagnosis was permitted for each admission, but up to 19 different secondary diagnoses were allowed. The secondary diagnosis was any condition that existed in addition to the primary reason as deemed relevant.
We extracted data on patient count, admission count (finished admission episodes), cost of admission, type of admission (elective/non-elective), coded reasons for admissions, in-hospital mortality, length of stay (LOS) and stays of greater than three months of duration. Average LOS was calculated by dividing total bed days by the total number of admissions. ZBDs were excluded from all analyses except original M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 6 headline rates to avoid skewing of the data and because these short admissions have less clinical and economic impact.
Parkinson's disease patients and controls
Patients with PD were identified by ICD-10 codes of G20X (Idiopathic PD) or F02.3 (Dementia in PD) either as a primary or secondary diagnosis. Patients under 35 years were excluded as PD is rare in this age group and may reflect coding errors.
The control group consisted of patients with admission codes excluding the ICD-10 codes G20X and F02.3 in any diagnostic field and fulfilling the same age criteria.
Assigning admissions to a specific 'HES year' is complex, as patients may already be in-patients at the start of the year or discharged after the end of the year. For all analyses, except mortality, patients who began their admission before the study start date, but were discharged during the study period, were included (0.3% of total admissions), but patients who were not discharged by the study end date were excluded (2.0% of total) as cost and LOS can only be calculated within HES for completed admissions.
For the mortality analysis, only admissions occurring entirely within the 4 year study period were used to ensure the appropriate denominator, (i.e. a patient would have to be admitted and discharged or died within the 4 year study period). 
Admission costs and excess bed days
Reasons for non-elective admissions
Common reasons for non-elective admissions for PD patients were identified using ICD-10 codes. Where G20X or F02.3 codes were secondary diagnoses, the ICD-10 codes listed as primary diagnosis were examined. Individual ICD-10 codes were grouped into larger sub-categories and stratified according to whether they were PDrelated or not, based on the consensus opinion of two clinicians (CEC and RW).
These were compared with data from the corresponding control group. Admission cost and EBD cost for each sub-category were calculated excluding the 'other' subcategory for controls, which proved impractical to calculate given the large numbers.
Statistical analysis
We present crude and age-and sex-specific descriptive statistics for PD and control groups for all admissions and specific diagnostic groups. Ideally, one would then test if certain conditions are more likely to result in a higher hospitalisation rate for PD patients than controls by calculating the relative admission rate. However, the HES Though census data can be used for the control populations, there is no equivalent data for PD patients and extrapolating from localised cross-sectional studies may be problematic, under-estimating the true population denominator, thereby inflating the PD rate. Therefore, we examined the proportion of admissions for a specific cause compared to all admissions for PD cases and controls. Age and sex were taken into account, as PD is more common in men and the prevalence increases with age.
Firstly, we present the PD and control data stratified by age groups and sex allowing comparison of age-and sex-specific proportions. Secondly, we used indirect standardisation, with proportions in the control population being the standard, so that we derived proportional ratios for cause-specific admissions and mortality analogous to standardised admission and mortality rates. [10] A ratio >1 indicates a greater proportion and a value <1 indicates a lower proportion. From this, we calculated the age-and sex-adjusted admission rate per 100 admissions. Finally, we used Poisson regression models using the count of condition-specific admissions as the outcome, all admissions as the denominator and an indicator variable for the PD versus control groups. We then adjusted for age group and sex in the multivariable models by using these as covariates. For LOS, we calculated the mean length for descriptive purposes but, because of data skewness, we only formally tested for differences by comparing the proportion with a LOS greater than three months (excessive stay) in the PD group with controls as above. 'under 35' years of age, 'unknown' age or 'unknown or unspecified sex' were omitted leading to 15,903,994 (24.2%) admissions being excluded. Of the remaining 49,874,100 admissions, 324,055 were generated by 182,859 PD patients (0.69%) and 49,550,045 by 26,419,116 controls almost three times the crude expected proportion over 35 years (0.24%) from two recent prevalence studies. [11, 12] The numbers excluded for reasons other than age <35 years accounted for less than 0.5% of the total cohort (0.2% of the PD group had missing covariates). 28% and 72% of PD admissions were elective and non-elective respectively compared to 60% and 40% in controls. Table 1 provides admission count and cost of admissions stratified by sex and age of elective and non-elective admissions for PD patients. Approximately 60% of the admissions were generated by male patients reflecting the higher male prevalence of PD. More admissions occurred in age groups above 65 years of age, with almost half of the admissions occurring in 75 to 84 year olds.
RESULTS
Between
The total cost of PD admissions over 4 years was £906,617,908. The cost per admission increased with increasing age, with the oldest age bracket (>85 year old) costing the most per admission ( Table 1 ). Whilst the proportion of non-elective admissions was 72%, the cost was disproportionately higher with non-elective admissions resulting in 86% (£777,476,489) of the total cost. The average cost per admission reflected this with elective and non-elective admissions costing £1,417 and £3,338 per admission, respectively. There were no differences in cost per admission between male and female patients.
After excluding ZBD admissions, the number of non-elective PD admissions was 204,266 costing £716,606,754 ( Table 2 ). Twelve percent of the total cost consisted of EBD costs, incurred due to exceptionally long inpatient stays. The largest category was 'other' (36.5%), consisting of over 100 ICD-10 codes recorded as a primary diagnosis, but appearing at low frequencies. Thereafter, the most common reasons for non-elective admissions probably related to PD were pneumonia (13.5%), "PD" itself (9.4%), urinary tract infection (UTI; 9.2%), and hip fractures (4.3%). Of these, "PD" and hip fracture incurred a higher percentage of the total costs (12% and 7.6% respectively) compared to the frequency in which they occurred in relation to the total number of admissions. In controls, the proportion of the non-elective admissions for pneumonia, UTI and hip fractures of the total were 7%, 2.9% and 1.6% respectively (Supplementary Table 1 ), indicating that these conditions were over-represented in patients with PD with unscheduled admissions.
The relative proportions for non-elective admissions between the PD and control groups are shown in Supplementary Table 3 for UTI, pneumonia, hip fracture, and other fracture. Age and sex-standardised risk and proportional admission ratio have been calculated for each condition (Supplementary Tables 2 and 3 ). The relative proportion of admissions for each of these conditions is substantially higher for each condition, especially UTI (ratio 2.63, 95% CI 2.59, 2.67, p<0.0001) with an age and sex standardised risk of 6 per 100 admissions. Pneumonia admissions were more common at 8.4 per 100 admissions, but the ratio was less elevated (ratio 1.55, 95% Figure 1 shows that mean LOS for non-elective admissions was consistently longer in PD patients than controls for both sexes and across all age groups. Mean LOS for PD patients was seven days longer than controls (16 versus 9 days). There was a trend for increasing mean LOS with increasing age in the PD group which was not mirrored in the control group. For the PD group, average LOS between the two sexes were comparable, apart from the '35 -44' year old where LOS for males was longer than females. PD patients were almost twice as likely to have admissions resulting in LOS greater than three months (ratio 1.90, 95% CI 1.83, 1.97, p<0.0001).
Mean LOS was longer in PD patients than controls for UTI, pneumonia, hip fracture, and other fractures ( Supplementary Table 4 ). Table 5 ) with a proportional mortality ratio of 2.46 (95%CI 2.42, 2.49, p<0.0001). The increase was particularly marked for those over 85 years, with around 10% of PD admissions resulting in death. £600 million at that time. [13] With such large sums, even small reductions in the numbers of non-elective admissions would lead to significant savings.
Mortality was increased in PD patients compared with controls (Supplementary
DISCUSSION
As expected, the admission count and cost per admission increased with age to around £3,200 per admission in those over 85 years. Increased co-morbidity in this age group may have led to more 'problems' being coded which would increase costs. Total annual direct healthcare costs also increased with age in the UKGPDS, from £3,978 per person less than 65 years to £9,393 per person over 85 years. [13] So, interventions focussed on older PD patients should have more financial impact.
Mean LOS for non-elective admissions was seven days longer in PD patients than controls. The annual cost of EBDs, relating to exceptionally long inpatient stays, for PD emergency admissions was over £22 million highlighting the potential for cost savings. Gerlach and colleagues systematic review of PD hospitalisation studies found that most previous studies had shown increased LOS in PD. [14] Most concerning of all is the excess mortality in admitted PD patients compared to controls, particularly for those over 85 years, with 10% of PD admissions resulting in death. This is consistent with a previous review of case-control and cohort studies showing an excess mortality ratio in PD of 2.56 (95% CI 2.46, 2.66, p<0.00001). [15] It has been shown that more than 50% of people with PD die in hospital, with nearly a third dying in care homes and a much smaller percentage dying at home. The most frequent reasons for non-elective admissions in our national sample were pneumonia (13.5%), advanced "PD" (9.4%), UTI (9.2%), and hip fractures (4.3%). This is in line with previous reports from individual institutions, [2] [3] [4] [5] [6] although the precise proportions differ, probably due to differences in coding. We have also shown that UTI, pneumonia, hip fractures and other fractures occur more frequently in PD than in age and sex matched controls, with proportional admission ratios from 1.5 to 2.6 times the control group. Several previous studies have shown an increased fracture rate in PD. In a study using the UK General Practice Research Database, the risks of any fracture and hip fracture were almost doubled and tripled for PD patients (adjusted hazard ratio any fracture 1.89, 95% CI; 1.67, 2.14; risk of hip fracture 3.08; 95%, CI 2.43, 3.89). [17] Similarly, using the UK National Hip Fracture Database, the relative risk of hip fracture for those aged over 60 years was 3.7 (95% CI 2.6, 5.3) for PD patients in Northumbria Healthcare NHS Foundation Trust in the UK. [18] Imbalance and falls are common in PD and poorly responsive to dopaminergic medication. Osteoporosis is common in PD in view of age and immobility, [19] so the increased risk of fracture is not surprising. Some of the increase of UTI may be due to over-diagnosis of UTI, but bladder function is affected in PD. [20] Pneumonia is due to a combination of deteriorating motor function and PD-related dysphagia and is a common cause of death. [21] It would seem appropriate to focus interventions to reduce admissions on these most common causes.
The key issue is to what degree could these admissions, the resulting costs and mortality be avoided by better care? We have summarised some potential Table 3 . [3, 19, [22] [23] [24] [25] [26] [27] [28] [29] The evidence base for some of these interventions is speculative and such processes will require careful evaluation before we can assume they are cost-effective. Healthcare systems already address some of these issues, but we suspect in an ad hoc manner rather than using a systematic approach. Different models of healthcare should be considered. For example, PD Nurse Specialists could lead an integrated community and secondary care team, combining the skills of primary care, hospital specialists, rehabilitation specialists, other allied healthcare specialties, and palliative care. This is the largest study of its kind with real-world direct healthcare costs on which reimbursement is based in England. Its main limitation is the reliance on routinely coded data with the potential for errors in both coding and costing. However, a recent systematic review noted that coding accuracy rates were improving and sufficiently robust for both research and managerial decision making. [30] An ongoing study examining electronic prescribing records in PD, in addition to the local ICD-10 returns, at Queen Elizabeth Hospital, Birmingham, UK suggests that ICD-10 returns miss over 15% of PD admissions (CEC personal communication). These data would suggest we may have under-estimated the size of the problem. We had to calculate the proportional risk ratios rather than ratios based on the true PD population at risk. This is unlikely to have biased our hospital-based mortality ratios or excessive lengths of stay but may have inflated the ratios for urinary tract infections, as PD patients are less likely to be admitted with smoking-related morbidity [31] and hence other admission causes, if unrelated to smoking, would appear relatively more important. However, as smoking predicts fracture risk, [32] then our observed estimates for fractures are likely to be an under-estimate. 
Prevention of admission& re-admission
All Open access to PD nurse service RCT 3, 23 Open access to PD clinic Evidence required
Better access to identified general practitioner Systematic review 22 Carer support Evidence required Improvement in the process of medicine administration in care homes and better communication between care homes and medical personnel (GPs and pharmacists)
Ethnographic study 27 Motor 
Improved management of admission
All Rapid access to rehabilitation team including physiotherapy, occupational therapy and speech and language therapy Systematic reviews 24, 26 Access to specialist PD ward Observational evidence 29 Adequate management for PD patients undergoing surgery Evidence 
